Sex Hormone Receptors in Benign and Malignant Salivary Gland Tumors: Prognostic and Predictive Role
Authors:
- Gabriella AquinoGAGabriella Aquino
- Francesca CollinaFCFrancesca Collina
- Rocco SabatinoRSRocco Sabatino
- Margherita CerroneMCMargherita Cerrone
- Francesco LongoFrancesco Longo
- Franco IonnaFIFranco Ionna
- Nunzia Simona LositoNLNunzia Simona Losito
- Rossella De CecioRCRossella De Cecio
- Monica CantileMonica Cantile
- Giuseppe PannoneGPGiuseppe Pannone
- Gerardo BottiGBGerardo Botti
Open Access
- 30 January 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (2) , 399
Abstract
The role of sex hormone receptors in human cancer development and progression has been well documented in numerous studies, as has the success of sex hormone antagonists in the biological therapy of many human tumors. In salivary gland tumors (SGTs), little and conflicting information about the role of the estrogen receptor alpha (ERα), progesterone receptor (PgR) and androgen receptor (AR) has been described and in most cases the use of sex hormone antagonists is not contemplated in clinical practice. In this study, we analyzed a panel of sex hormone receptors that have not been widely investigated in SGTs—ERα, PgR, AR, but also ERβ and GPR30—to define their expression pattern and their prognostic and predictive value in a case series of 69 benign and malignant SGTs. We showed the aberrant expression of AR in mucoepidermoid and oncocytic carcinoma, a strong relation between cytoplasmic ERβ expression and tumor grade, and a strong correlation between nuclear GPR30 expression and disease-free survival (DFS) of SGT patients.Keywords
This publication has 48 references indexed in Scilit:
- Sex Differences and Sex Steroids in Lung Health and DiseaseEndocrine Reviews, 2012
- MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cellsBreast Cancer Research, 2012
- Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivityThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)Oral Oncology, 2009
- In vivo effects of a GPR30 antagonistNature Chemical Biology, 2009
- G Protein–Coupled Receptor 30 (GPR30) Mediates Gene Expression Changes and Growth Response to 17β-Estradiol and Selective GPR30 Ligand G-1 in Ovarian Cancer CellsCancer Research, 2007
- GPR30: A G protein-coupled receptor for estrogenMolecular and Cellular Endocrinology, 2007
- Biological Role of Estrogen Receptor β in Salivary Gland Adenocarcinoma CellsClinical Cancer Research, 2006
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Estrogen and progesterone receptors in salivary gland adenoid cystic carcinomaOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1995